Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Thrombosis Research
|
February 7, 2018
Point of Care Testing (POCT) to assess drug concentration in patients treated with non-vitamin K antagonist oral anticoagulants (NOACs)
S Padayattil Jose, A Banzato, P Carraro, et al.
The American Journal of Cardiology
|
September 2, 1998
Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillation
V Pengo, A Zasso, F Barbero, et al.
Thrombosis Research
|
May 31, 2011
Antibodies to Domain I of β(2)Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS)
A Banzato, N Pozzi, R Frasson, et al.
Thrombosis Research
|
May 12, 2015
Antibodies to Domain 4/5 (Dm4/5) of β2-Glycoprotein 1 (β2GP1) in different antiphospholipid (aPL) antibody profiles
V Pengo, A Ruffatti, M Tonello, et al.
Journal of Thrombosis and Haemostasis : JTH
|
January 10, 2018
Thrombocytopenia in high-risk patients with antiphospholipid syndrome
E Pontara, A Banzato, E Bison, et al.
Journal of Thrombosis and Haemostasis : JTH
|
April 23, 2013
Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile
V Pengo, A Ruffatti, T Del Ross, et al.
Journal of Thrombosis and Haemostasis : JTH
|
April 13, 2013
β2 -Glycoprotein I binds to thrombin and selectively inhibits the enzyme procoagulant functions
N Pozzi, L Acquasaliente, R Frasson, et al.
Lupus
|
May 29, 2012
Circulating β2 glycoprotein I-IgG anti-β2 glycoprotein I immunocomplexes in patients with definite antiphospholipid syndrome
A Banzato, R Frasson, L Acquasaliente, et al.
Journal of Thrombosis and Haemostasis : JTH
|
October 31, 2009
Clinical course of high-risk patients diagnosed with antiphospholipid syndrome
V Pengo, A Ruffatti, C Legnani, et al.
Thrombosis Research
|
June 15, 2010
Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA)
V Pengo, G Denas, E Bison, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Thrombosis Research
|
February 7, 2018
Point of Care Testing (POCT) to assess drug concentration in patients treated with non-vitamin K antagonist oral anticoagulants (NOACs)
S Padayattil Jose, A Banzato, P Carraro, et al.
The American Journal of Cardiology
|
September 2, 1998
Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillation
V Pengo, A Zasso, F Barbero, et al.
Thrombosis Research
|
May 31, 2011
Antibodies to Domain I of β(2)Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS)
A Banzato, N Pozzi, R Frasson, et al.
Thrombosis Research
|
May 12, 2015
Antibodies to Domain 4/5 (Dm4/5) of β2-Glycoprotein 1 (β2GP1) in different antiphospholipid (aPL) antibody profiles
V Pengo, A Ruffatti, M Tonello, et al.
Journal of Thrombosis and Haemostasis : JTH
|
January 10, 2018
Thrombocytopenia in high-risk patients with antiphospholipid syndrome
E Pontara, A Banzato, E Bison, et al.
Journal of Thrombosis and Haemostasis : JTH
|
April 23, 2013
Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile
V Pengo, A Ruffatti, T Del Ross, et al.
Journal of Thrombosis and Haemostasis : JTH
|
April 13, 2013
β2 -Glycoprotein I binds to thrombin and selectively inhibits the enzyme procoagulant functions
N Pozzi, L Acquasaliente, R Frasson, et al.
Lupus
|
May 29, 2012
Circulating β2 glycoprotein I-IgG anti-β2 glycoprotein I immunocomplexes in patients with definite antiphospholipid syndrome
A Banzato, R Frasson, L Acquasaliente, et al.
Journal of Thrombosis and Haemostasis : JTH
|
October 31, 2009
Clinical course of high-risk patients diagnosed with antiphospholipid syndrome
V Pengo, A Ruffatti, C Legnani, et al.
Thrombosis Research
|
June 15, 2010
Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA)
V Pengo, G Denas, E Bison, et al.
Page
of 4